Limitations Direct clinical evidence for this specific molecule is limited
TB-500 (Thymosin Beta-4): The recovery accelerator Rogan has also discussed TB-500 , often in the context of stacking it with BPC-157 for comprehensive healing support
A meta-analysis of more than 30 trials found that the overall remission rate of MALT lymphomas with a low histological grade that is restricted to the perigastric lymph nodes or the gastric wall (stage I or stage IIe 1 illness) was 78% (107)
BPC-157 has been researched for supporting gut health issues (inflammatory bowel conditions, leaky gut), tendon and ligament injuries, muscle tears, joint issues, post-surgical recovery, wound healing, and chronic inflammation
The results of early clinical trials with ARO-ANG3 demonstrated reductions in circulating levels of ANGPTL3 of up to 84%, reductions in circulating triglyceride levels of up to 58%, and reductions of non-HDL cholesterol of up to 26%
Glutathione strengthens immune cell activity, regulates immune responses to prevent overreaction, and blocks a central inflammation control pathway in the body